Clinical Trial

Preoperative Anxiety and Surgical Fear in Holmium Laser Enucleation of the Prostate and Transurethral Resection of the Prostate Patients With Benign Prostatic Hyperplasia

Study acronym: HoLEP and TURP
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Benign prostatic hyperplasia (BPH) is a common condition in older men and may cause bothersome lower urinary tract symptoms that can negatively affect quality of life. Surgical treatment with Holmium Laser Enucleation of the Prostate (HoLEP) or Transurethral Resection of the Prostate (TURP) is often recommended when medical therapy is insufficient. This prospective observational study aims to evaluate whether preoperative anxiety, depression, and surgical fear influence postoperative functional outcomes, urinary continence, erectile function, and patient satisfaction in patients undergoing HoLEP or TURP for BPH. Participants will complete validated psychological and functional questionnaires before surgery and during postoperative follow-up visits at 1 and 3 months. The study will also assess changes in psychological status after surgery and compare outcomes between HoLEP and TURP patients. The findings may help improve preoperative patient counseling and identify patients who could benefit from additional psychological support before surgery.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-17.
Trial Details
NCT Number NCT07663097
Lead Sponsor Hitit University
Conditions Benign Prostatic Hyperplasia
Enrollment 80 participants
Start Date 2026-06-14
Primary Completion 2027-04-08 (estimated)
Study Completion 2027-06-08 (estimated)
Updated on ClinicalTrials.gov 2026-06-26